Bryan Laffitte
Executive Director Novartis Neuroscience; Head of Genetic Medicines
- Role
- Executive Director at Novartis
- Location
- San Diego, CA, US
- LinkedIn followers
- 500 followers
About Bryan Laffitte
Chief Scientific Officer of DTx Pharma leveraging 20 years’ experience in biotech and major pharmaceutical companies to help move our science to the next level.Scientist of the Year and VIVA Award winner for 2016 at Novartis. Previously the Director of Regenerative Medicine, Head of Type 1 Diabetes Program and Co-Leader of the Molecular Targeting Initiative at the Genomics Institute of the Novartis Research Foundation. Initiated and led FXR agonist project at Novartis from initial concept to multiple positive Phase 2 clinical trials; developed tropifexor, the cornerstone of Novartis Hepatology, and backup compound nidufexor. Extensive experience in the evaluation of therapeutic targets, drug development, and delivery of high-quality clinical candidates in multiple disease areas, including endocrinology, hepatology and oncology.Former leadership team member founding new companies at Inception Therapeutics.
Experience
Executive Director
Jan 2024 — Present · San Diego, CA, US
Head of Novartis Neuroscience Genetic Medicines Unit
Education
UCLA
Ph.D., Biological Chemistry
1995 — 2000
Skills
- Cell Biology
- Biochemistry
- High Throughput Screening
- Drug Discovery
- Pharmacology
- Cell
- In Vitro
- Assay Development
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.